3rd International Conference of Federation of Asian Clinical Oncology (FACO)

October 29(Thu) - 31(Sat), 2015 Kyoto International Conference Center

Abstracts Submission

3rd FACO welcomes your abstract submission for presentations at 3rd International Conference of Federation of Asian Clinical Oncology (FACO) in October 29-31, 2015.

  • Submission Period
  • Submission Requirements
  • Submission Process
  • Presentation Style
  • Important Notes for Submission
  • COI Disclosure
  • Categories
  • Notification for Acceptance of Abstracts, Presentation Style & Date/Time
  • Online Abstract Submission System
  • Inquiries

Submission Period

General : March 3 (Tue) noon JST - May 7 (Thu) noon JST, 2015
Invited Speakers : Early April - May 22 (Fri) noon JST, 2015
*JST = Japan Standard Time

Submission Requirements

The head/presenting author should enter abstract information including: title of the abstract, name, affiliation, postal address, and email address for each author.

Submission Process

Abstract submission is accepted only through Online Abstract Submission system. Please access to the abstract submission page from the link button at the bottom of this page.

General

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Click the "Registration as the head author" in Non-Members category located at the bottom of Top page, and open the registration page.
Step 3 Enter your personal information on "Create New Account "page.
Step 4 Once the personal information registration completes, the message for completion will be shown together with your 1) ID for Abstract Submission, 2) Log-in ID, 3) Password on the screen.Also, a confirmation email titled "My Account / Confirmation" will be sent to your registered email address. If you do not receive a confirmation email, please contact Abstract Division of Management Secretariat at endai-jsco2015[A]convention[D]co[D]jp ( Please change[A] to @ , [D] to . )
Step 5 By clicking the button of " to TOP Page" at the foot of Registration Completion Page (mentioned on STEP 4 above), or by entering newly issued IDs and Password from Top page, you can confirm your personal information or enter your abstracts.
Step 6 Once the abstract registration completes, the message for completion will be shown together with your 1) ID for Abstract Submission, 2) Log-in ID, 3) Password on the screen. Also, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email in 30minutes, please contact Abstract Division of Management Secretariat at endai-jsco2015@convention.co.jp.
* For security reasons, we are not able to answer any questions about your passwords.

Invited Speakers

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Please enter, your Access ID, Login ID, and Password which are provided in the e-mail sent from Secretariat Office. Then, click "Sign in" button.
Step 3 Please check your information in "Your Profile" and "Head Author's Information" sections. Then, click "Biography" button to enter your biography, and click "Abstract Submission for Invited Speakers" button for abstract submission.
Step 4 Once the abstract registration completes, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email in 30minutes, please contact Overseas Division of Management Secretariat at overseas-jsco2015@convention.co.jp.

Presentation Style

Your abstract will be for International Session. Please select your preference for presentation, either "Poster Only" or "Poster or Oral".

Important Notes for Submission

Items marked with " * asterisk" are the required information. If you fail to complete those required information, you are not able to proceed for registration.
Please answer the questions in each page, including COI Disclosure, Personal Information, Agreement on Submission, and Copyright.

Limitation for Registration

Total number of authors (first author and co-authors) up to 15 authors
Total number of Affiliations  Up to 15 affiliations
Total number of characters for Abstract Title 200 characters
or approx. 28 words (including spaces)
Total number of characters for Abstract body 2,000 characters
or approx. 290 words (including spaces)

Disclosure of COI (Conflict of Interest)

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.
From JSCO Annual Meeting in 2007, Clinical Oncology Research Conflict of Interest Policy was established, and in order to secure the fairness of the presentations for clinical research at Annual Meetings, conflicts of interest that presenting authors are obligated to disclose the COI status from 2008. Moreover, the guideline enforced from April, 2013, which is called "Oncology Research Conflict of Interest Policy" and it applies not only for clinical research, but also all medical studies including bioscience research, basic medical research, and clinical trials.
Matters for which disclosure is required shall be matters that occur from two year before abstract submission to the time of presentation; it is provided. Please refer to the COI page on Online Abstract Submission system for details, and mark the boxes which match with your status. The amounts for which self-declaration is required are prescribed for each matter requiring disclosure as follows. Presenting authors who are officers or advisors of companies or for-profit organizations, or the profit from sales of stock, or patent royalties or licensing fees from companies are 1 million yen or more. Honoraria (such as lecture fees) or report manuscript fees paid by a company are 500,000 yen or more. Report research funding is 2,000,000 yen or more. For more details about COI, please refer to JSCO Website.

COI Disclosure Sample Form

(1) Specialization

01 Internal medicine 08 Ophthalmology 15 Basic medicine
02 Surgery 09 Otolaryngology 16 Clinical pathology
03 Obstetrics & Gynecology 10 Dermatology 17 Neuropsychiatry
04 Radiology 11 Pediatric 18 Palliative medicine
05 Urology 12 Anesthesiology 19 Pharmacology
06 Orthopedics 13 Neurosurgery 20 Others
07 Oral surgery 14 Plastic surgery    

(2) Areas of Research: Classified by Organ, etc.

01 Pediatrics 09 Small / Large Intestine 17 Kidney / Urinary Tract / Bladder
02 Neurologic 10 GIST (Gastrointestinal Stromal Tumor) 18 Prostate / Male Genital
03 Eyes 11 Liver 19 Endocrine
04 Oral Cavity 12 Gallbladder / Biliary Tract 20 Skin
05 Head and Neck 13 Pancreas 21 Bone and Soft Tissue
06 Breast 14 Lung / Mediastinum/Pleura 22 Hematopoietic Organs / Lymphatic System
07 Esophagus 15 Uterus 23 NET (Neuroendocrine Tumor)
08 Stomach / Duodenum 16 Ovary 24 Others

Notification for Acceptance of Abstracts, Presentation Style & Date/Time

All abstracts submitted will be reviewed by the congress, and the first/presenting author will be notified the decision of Acceptance / Rejection by email from Abstract Division of Management Secretariat at endai-jsco2015@convention.co.jp. Your presentation style and date/time will be also notified in later days.

Online System

To submit your abstract, click here

Inquiries for Abstract Submission

Abstract Division of Management Secretariat
Japan Convention Services, Inc., IT Center
Koshin Bldg., 2F, 2-2 Kandanishicho, Chiyoda-ku, Tokyo 101-0054 Japan
TEL: +81-3-3500-5935
FAX: +81-3-5283-5952
E-mail: endai-jsco2015[A]convention[D]co[D]jp ( Please change[A] to @ , [D] to . )

Page Top